논문 상세보기

쥐오줌풀 추출물이 MIA동물모델에서의 신경발달 단백질의 발현과 행동증상에 미치는 영향 KCI 등재

Effect of Valeriana fauriei Extract on the Neurodevelopmental Proteins Expression and Behavioral Patterns in Maternal Immune Activation Animal Model

  • 언어KOR
  • URLhttps://db.koreascholar.com/Article/Detail/327541
서비스가 종료되어 열람이 제한될 수 있습니다.
한국약용작물학회지 (Korean Journal of Medical Crop Science)
한국약용작물학회 (The Korean Society of Medicinal Crop Science)
초록

Background: Prenatal exposure to infectious and/or inflammatory insults can increase the risk of developing neuropsychiatric disorder such as bipolar disorder, autism, and schizophrenia later in life. We investigated whether Valeriana fauriei (VF) treatment alleviates prepulse inhibition (PPI) deficits and social interaction impairment induced by maternal immune activation (MIA).Methods and Results: Pregnant mice were exposed to polyriboinosinic-polyribocytidilic acid (5㎎/㎏, viral infection mimic) on gestational day 9. The adolescent offspring received daily oral treatment with VF (100㎎/㎏) and injections of clozapine (5㎎/㎏) for 30 days starting on the postnatal day 35. The effects of VF extract treatment on behavioral activity impairment and protein expression were investigated using the PPI analysis, forced swim test (FST), open field test (OFT), social interaction test (SIT), and immunohistochemistry. The MIA-induced offspring showed deficits in the PPI, FST, OFT, and SIT compared to their non MIAinduced counterparts. Treatment with the VF extract significantly recovered the sensorimotor gating deficits and partially recovered the aggressive behavior observed in the SIT. The VF extract also reversed the downregulation of protein expression induced by MIA in the medial prefrontal cortex.Conclusions: Our results provide initial evidence of the fact that the VF extract could reverse MIA-induced behavioral impairment and prevent neurodevelopmental disorders such as schizophrenia.

저자
  • 원한솔(순천향대학교 의과대학 임상약리학교실) | Hansol Won (Department of Clinical Pharmacology, College of Medicine, Soonchunhyang University, Cheonan 31151, Korea.)
  • 김영옥(농촌진흥청 국립원예특작과학원 인삼특작부) | Young Ock Kim (Development of Ginseng and Medical Plants Research Institute, NIHHS, RDA, Eumseong 27709, Korea.)
  • 이화영(순천향대학교 의과대학 임상약리학교실) | Hwayoung Lee (Department of Clinical Pharmacology, College of Medicine, Soonchunhyang University, Cheonan 31151, Korea.)
  • 임지윤(순천향대학교 의과대학 임상약리학교실) | Jiyun Im (Department of Clinical Pharmacology, College of Medicine, Soonchunhyang University, Cheonan 31151, Korea.)
  • 이상현(중앙대학교 생명공학대학 식물시스템과학과) | Sanghyun Lee (Department of Integrative Plant Science, Chungang University, Anseong 17546, Korea.)
  • 조익현(경희대학교 한의과대학 융합의과학교실) | Ik Hyun Cho (Department of Convergence Medical Science, Brain Korea 21 Plus Program, and Institute of Korean Medicine, College of Oriental Medicine, Kyunghee University, Seoul 02453, Korea.)
  • 이상원(농촌진흥청 국립원예특작과학원 인삼특작부) | Sang Won Lee (Development of Ginseng and Medical Plants Research Institute, NIHHS, RDA, Eumseong 27709, Korea.)
  • 박춘근(농촌진흥청 국립원예특작과학원 인삼특작부) | Chun Geun Park (Development of Ginseng and Medical Plants Research Institute, NIHHS, RDA, Eumseong 27709, Korea.)
  • 김형기(순천향대학교 의과대학 임상약리학교실) | Hyung Ki Kim (Department of Clinical Pharmacology, College of Medicine, Soonchunhyang University, Cheonan 31151, Korea.)
  • 권준택(순천향대학교 의과대학 임상약리학교실) | Jun Tack Kwon (Department of Clinical Pharmacology, College of Medicine, Soonchunhyang University, Cheonan 31151, Korea.)
  • 김학재(순천향대학교 의과대학 임상약리학교실) | Hak Jae Kim (Department of Clinical Pharmacology, College of Medicine, Soonchunhyang University, Cheonan 31151, Korea.) Corresponding author